Hepatic transarterial chemoembolization and retroperitoneal lymph node radiofrequency ablation in the multidisciplinary approach of an overt metastatic leiomyosarcoma

Metastatic leiomyosarcoma has a dismal prognosis, and therapy mainly consists of palliative systemic chemotherapy. A selected subgroup of patients with limited metastatic disease may eventually derive benefit from more aggressive strategies, including resection of isolated metastasis. We report here...

Descripción completa

Detalles Bibliográficos
Autores principales: de Lima Araujo, Luiz Henrique, Gouveia, Hugo Rodrigues, de Queiroz Freitas, Emilson, Vilela Pedras, Felipe, Luz, José Hugo Mendes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: e-Med 2013
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613790/
https://www.ncbi.nlm.nih.gov/pubmed/23545154
http://dx.doi.org/10.1102/1470-7330.2013.0014
Descripción
Sumario:Metastatic leiomyosarcoma has a dismal prognosis, and therapy mainly consists of palliative systemic chemotherapy. A selected subgroup of patients with limited metastatic disease may eventually derive benefit from more aggressive strategies, including resection of isolated metastasis. We report here the successful use of hepatic transarterial chemoembolization and retroperitoneal lymph node radiofrequency ablation in a patient with advanced leiomyosarcoma metastatic to the liver and retroperitoneum.

Ejemplares similares